v3.25.2
Share based payment
12 Months Ended
Mar. 31, 2025
Share Based Payment [Abstract]  
Share based payment
39.
Share based payment
a)
Replacement of Group Stock Option Plans

On August 23, 2021, all vested and unvested options outstanding for Group Stock Option Plans were replaced by the ‘2021 Stock Entitlement Program’ of the Company (Holding Company Stock Option Plans) with similar terms as per the original options. The employees of the Group were entitled to 0.8289 Holding Company Stock Option for every one Group Stock Option held for both vested and unvested options with no changes in vesting period and exercise period. The exercise price of Group Stock Option, which was fixed in INR, got converted into US Dollars using exchange rate as on the date of replacement, as exercise price of Holding Company Stock Option.

The Holding Company Stock Option Plans granted to the employees will be settled in Class A share of the Company. Therefore, the Holding Company Stock Option Plans have been classified as an equity settled share based payment. The replacement of Group Stock Option Plans with Holding Company Stock Option Plans is identified as replacement plan and accounted for as a modification of the Group Stock Option Plans. ESOP expenses [grant date fair value as per Group Stock Option Plans plus incremental fair value (if any) measured at the date of replacement] related to employees of the Group are recognised as employees’ expenses, over vesting period. The modification reduces the fair value of the stock options granted, measured immediately before and after the modification, and therefore the Group has not taken into account that decrease in fair value and had continued to measure the amount recognised for services received based on the grant date fair value of the Group Stock Option Plans granted. Pursuant to replacement of stock options, on the date of replacement, 6,933,865 vested and 7,146,270 unvested option of Group Stock Option Plans got replaced with 5,747,481 vested and 5,923,543 unvested Holding Company Stock Option Plans.

The fair value of stock options was estimated at the date of replacement using Black-Scholes valuation model, taking into account the terms and conditions upon which the share options were granted. Following are the assumptions used in valuation of Holding Company Stock Option Plan as on the date of replacement:

 

Particulars

 

Group Stock
Option Plans

 

Holding Company
Stock Option Plans

Dividend yield (%)

 

0.0%

 

0.0%

Expected volatility (%)

 

25.67% - 37.87%

 

33.43% - 49.97%

Risk–free interest rate (%)

 

3.29% - 6.39%

 

0.05% - 1.03%

Weighted average expected life of options granted

 

0.07 years - 6.86 years

 

0.07 years - 6.86 years

Weighted average share price

 

INR 606.96

 

USD 8.17

 

The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.

The relevant terms of the Holding Company Stock Option Plans are as below:

 

 

Holding Company Stock Option Plans

Particulars

2018 Stock Option Plan Modified

 

2018 Stock Option Plan

 

2017 Stock Option Plan

 

2016 Stock Option Plan

 

2014 Stock Option Plan

 

2011 Stock Option Plan

Grant date

August 16, 2019

 

Multiple

 

Multiple

 

Multiple

 

Multiple

 

Multiple

Replacement date

August 23, 2021

 

August 23, 2021

 

August 23, 2021

 

August 23, 2021

 

August 23, 2021

 

August 23, 2021

Vesting period

Time linked vesting:
Grants will vest in
5 years on quarterly basis which shall commence one year after the date of original grant of options.

 

Time linked vesting:
50 % of grants will vest in 5 years as follows:
i) One year from the date of original grant, the Options for the first four quarters shall vest immediately.
ii) Thereafter, vesting will continue on a quarterly basis for the unvested Options.
Remaining
50% will vest at the end of 5 years from the date of original grant.

 

Time linked vesting:
50 % of grants will vest in 5 years as follows:
i) One year from the date of original grant, the Options for the first four quarters shall vest immediately.
ii) Thereafter, vesting will continue on a quarterly basis for the unvested Options.
Remaining
50% will vest at the end of 5 years from the date of original grant.

 

Time linked vesting:
5 years on quarterly basis effective from December 1, 2015 on completion of one year from the date of original grant, the Options for the first seven quarters shall vest immediately. Thereafter, vesting will continue on quarterly basis for the unvested Options commencing from December 1, 2017.

Performance linked vesting:
The Options shall vest annually and shall be prorated over a period of 3 years from the date of grant and shall be subject to the EBITDA achieved by the Company for the last completed financial year. The vesting of the Options shall take place at the end of the first anniversary of the date of original grant (Vesting date) and thereafter on March 31, 2018 and March 31, 2019 or at a later date when the audited financial statements of RPL are available.

 

Time linked vesting:
5 years on quarterly basis which shall commence one year after the date of original grant of option.

 

Time linked vesting:
5 years from the original grant date.

 

 

 

 

 

 

 

 

 

 

 

 

Exercise period

Within 10 years from the date of original grant upon vesting

Exercise price

USD 5.33

 

USD 5.33, 5.53 and 5.60

 

USD 4.53

 

USD 2.73

 

USD 1.75

 

USD 1.33

Settlement type

Equity settled

Expiry date

August 16, 2029

 

April 24, 2028 to
December 31, 2030

 

April 10, 2027 to
February 25, 2028

 

September 30, 2026

 

December 31, 2022 to
January 1, 2025

 

September 30, 2021 to
December 31, 2022

 

Number of options outstanding as at (in million):

 

March 31, 2025

 

1

 

 

 

1

 

 

 

7

 

 

 

1

 

 

 

1

 

 

 

1

 

March 31, 2024

 

1

 

 

 

1

 

 

 

7

 

 

 

1

 

 

 

1

 

 

 

1

 

 

The details of options outstanding are summarized below:

 

Particulars

 

Number of
options
(in million)

 

Outstanding as at April 1, 2022

 

 

12

 

Exercised / lapsed during the year

 

 

1

 

Outstanding as at March 31, 2023

 

 

11

 

Exercised / lapsed during the year

 

 

0

 

Outstanding as at March 31, 2024

 

 

11

 

Exercised / lapsed during the year

 

 

0

 

Outstanding as at March 31, 2025

 

 

11

 

 

 

 

 

 

 

 

Exercisable as at March 31, 2024

 

 

11

 

Exercisable as at March 31, 2025

 

 

11

 

 

 

-

The weighted average exercise price of these options outstanding was USD 4.20 for the period ended March 2025 (March 31,2024: USD 4.20).

 

 

-

The weighted average exercise price of exercisable options was USD 4.20 for the year ended March 31, 2025 (March 31, 2024: USD 4.20).

 

 

-

The weighted average exercise price of replacement of Group Stock Option Plans was USD 4.20 for the year ended March 31, 2025 (March 31, 2024: USD 4.20)

 

 

-

The weighted average exercise price of options exercised during the year was USD 4.13 for year ended March 31, 2025 (March 31, 2024: USD 2.15)

 

 

-

The weighted average remaining contractual life of options outstanding as at March 31, 2025 was 2.06 years (March 31, 2024: 2.97 years)

 

 

-

There were 17,254 options exercised during the year ended March 31, 2025 (March 31, 2024: 148,638 options)

 

 

b)
2021 Incentive Award Plan granted during the period August 23, 2021 to March 31, 2025

The Company introduced the 2021 Incentive Award Plan (Incentive Plan) to grant options to selected employees of the Group. The relevant terms of the Incentive Plan are as below:

According to this scheme, the employees selected by the compensation committee from time to time will be entitled to options as per grant letter issued by the compensation committee, subject to satisfaction of prescribed vesting conditions. The employees will be issued class A equity share of the Company on exercises of this incentive plan.

 

Particulars

2021 Incentive Plan

Grant date

February 10, 2025

October 23, 2024

August 23, 2024

May 24, 2024

May 15, 2024

April 10, 2024

April 1, 2024

April 1, 2024

Vesting period

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria.

12.5% shares to vest on last day of each quarter starting from Sep 2023 until entire subsequent option grant gets vested.

Restricted Stock Units (RSUs)
On the 1st anniversary of the Grant Date -
33%;
On the 2nd anniversary of the Grant Date –
33%;
On the 3rd anniversary of the Grant Date –
34%

Performance Based Units (PBUs)
On the 3rd anniversary of the Grant Date –
100% subject to achievement of Performance Metrics

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Performance criteria.

Restricted Stock Units (RSUs)
On the 1st anniversary of the Grant Date -
33%;
On the 2nd anniversary of the Grant Date –
33%;
On the 3rd anniversary of the Grant Date –
34%

Performance Based Units (PBUs)
On the 3rd anniversary of the Grant Date –
100% subject to achievement of Performance Metrics

Restricted Stock Units (RSUs)
On the 1st anniversary of the Grant Date -
33%;
On the 2nd anniversary of the Grant Date –
33%;
On the 3rd anniversary of the Grant Date –
34%

Performance Based Units (PBUs)
On the 3rd anniversary of the Grant Date –
100% subject to achievement of Performance Metrics

Exercise period

Within 10 years from the date of grant upon vesting

Within 8 years from date of grant upon vesting

Within 10 years from the date of grant upon vesting

Within 8 years from date of grant upon vesting

Exercise price

USD 6.38

USD 5.95

USD 10

USD 0.0001

USD 6.06

USD 6.84

USD 0.0001

USD 0.0001

Settlement type

Equity Settled

Expiry date

February 10, 2035

October 23, 2034

August 23, 2034

May 24, 2032

May 15, 2034

April 10, 2034

April 1, 2032

April 1, 2032

 

Number of options outstanding as at (in million):

 

March 31, 2025

 

0

 

 

0

 

 

4

 

RSU- 0
PBU-
0

 

 

4

 

 

4

 

RSU- 0
PBU-
0

 

RSU- 1
PBU-
0

 

March 31, 2024

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

 

Particulars

2021 Incentive Plan

Grant date

February 15, 2024

November 1, 2023

October 27, 2023

September 13, 2023

September 13, 2023

August 23, 2023

July 7, 2023

June 5, 2023

Vesting period

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

Restricted Stock Units (RSUs)
On the 1st anniversary of the Grant Date -
33%;
On the 2nd anniversary of the Grant Date –
33%;
On the 3rd anniversary of the Grant Date –
34%

Performance Based Units (PBUs)
On the 3rd anniversary of the Grant Date –
100% subject to achievement of Performance Metrics.

12.5% shares to vest on last day of each quarter starting from Septemner 2023 untill entire subsequent option grant gets vested.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

Exercise period

Within 10 years from the date of grant upon vesting

Within 8 years from date of grant upon vesting

Within 10 years from the date of grant upon vesting

Exercise price

USD 6.84

USD 5.78

USD 5.34

USD 5.87

USD 0.0001

USD 10.00

USD 5.48

USD 5.34

Settlement type

Equity Settled

Expiry date

February 15, 2034

November 1, 2033

October 27, 2033

September 13, 2033

August 22, 2031

August 23, 2033

July 7, 2033

June 5, 2033

 

Number of options outstanding as at (in million):

 

March 31, 2025

 

0

 

 

0

 

 

1

 

 

9

 

RSUs- 1; PBUs- 1

 

4

 

 

0

 

 

0

 

March 31, 2024

 

0

 

 

0

 

 

1

 

 

9

 

RSUs- 1; PBUs- 1

 

4

 

 

0

 

 

0

 

 

 

Particulars

2021 Incentive Plan

Grant date

March 15, 2023

November 15, 2022

September 15, 2022

August 22, 2022

June 10, 2022

August 23, 2021, November 15, 2021 and March 15, 2022

August 23, 2021

Vesting period

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

12.5% of stock options will vest at the end of each quarter over a period of 2 years in a time based manner.

Grant 1
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's Performance criteria.
 
Grant 2
80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 10% of stock options will vest at every anniversary of the grant date based on Company's Performance criteria

80% of options will vest over a period of 4 years in a time based manner, out of which 20% will vest after one year and remaining 60% will vest over the next 12 quarters (i.e. 5% in each quarter).
In addition, out of the remaining
20% option, 5% of stock options will vest at every anniversary of the grant date based on Company's performance.

6.25% of stock options will vest at the end of each quarter over a period of 4 years in a time based manner.

Exercise period

Within 10 years from the date of grant upon vesting

Exercise price

USD 5.85

USD 6.83

USD 10.00

USD 10.00

USD 10.00

USD 10.00

USD 10.00

Settlement type

Equity Settled

Expiry date

March 15, 2033

November 15, 2032

September 15, 2032

August 23, 2032

June 10, 2032

August 23, 2031 to
February 23, 2032

August 23, 2031

 

Number of options outstanding as at (in million):

 

March 31, 2025

 

0

 

 

0

 

 

0

 

 

4

 

 

1

 

 

6

 

 

23

 

March 31, 2024

 

0

 

 

1

 

 

0

 

 

4

 

 

1

 

 

7

 

 

23

 

 

The fair value of stock options was estimated using Black-Scholes valuation model, taking into account the terms and conditions upon which the share options were granted. Following are the assumptions used in valuation of 2021 Incentive Award Plan:

 

 

 

 

For the year ended March 31,

2021 Incentive Award Plan

 

2024

 

2025

Dividend yield (%)

 

0.0%

 

0.0%

Expected volatility (%)

 

25.68% to 41.23%

 

28.52% to 33.90%

Risk–free interest rate (%)

 

0.78% to 5.42%

 

3.64% to 5.21%

Weighted average expected life of options granted

 

8 to 10 years

 

8 to 10 years

Weighted average share price

 

USD 4.98 to USD 9.65

 

USD 5.22 to USD 7.46

 

The expected volatility reflects the assumption that the historical volatility over a period similar to the life of the options is indicative of future trends, which may not necessarily be the actual outcome.

The details of options outstanding are summarized below:

 

Particulars

 

Number of options (in million)

 

Outstanding as at April 1, 2022

 

 

30

 

Granted during the year

 

 

6

 

Exercised / lapsed during the year

 

 

0

 

Outstanding as at March 31, 2023

 

 

36

 

Granted during the year

 

 

16

 

Lapsed during the year

 

 

 

 

 

1

 

Outstanding as at March 31, 2024

 

 

51

 

Granted during the year

 

 

7

 

Lapsed during the year

 

 

1

 

Outstanding as at March 31, 2025

 

 

57

 

 

 

 

 

 

 

 

Exercisable as at March 31, 2025

 

 

40

 

Exercisable as at March 31, 2024

 

 

25

 

 

-

The weighted average exercise price of these options outstanding was USD 8.56 for the year ended March 31, 2025 (March 31, 2024: USD 8.81)

 

 

-

The weighted average exercise price of these options granted was USD 7.15 for the year ended March 31, 2025 (March 31, 2024: USD 6.36)

 

 

-

The weighted average exercise price of exercisable options was USD 9.47 for the year ended March 31, 2025 (March 31, 2024: USD 9.97)

 

 

-

The weighted average remaining contractual life for the share options outstanding as at March 31, 2025 was 7.27 years (March 31, 2024: 8.14 years).

 

 

-

There were 121,299 options (March 31, 2024: Nil) exercised during the year.

 

c)
Expenses arising from share-based payment transactions

The expense recognised for employee services received during the year is shown in the following table:

 

 

 

 

 

 

 

 

For the year ended March 31,

 

Particulars

 

 

 

 

 

 

2023

 

 

2024

 

 

2025

 

Expense arising from equity-settled share-based payment transactions

 

 

2,512

 

 

 

2,278

 

 

 

2,402

 

Total expense arising from share-based payment transactions*

 

 

2,512

 

 

 

2,278

 

 

 

2,402

 

 

* This amount is inclusive of amount capitalised in different projects.